Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2013; 19(21): 3189-3198
Published online Jun 7, 2013. doi: 10.3748/wjg.v19.i21.3189
Published online Jun 7, 2013. doi: 10.3748/wjg.v19.i21.3189
Tumor | Role | Clinicopathological relationships | Prognostic significance | Ref. |
Esophageal | ||||
Squamous cell carcinoma | Tumor-promoting | ↑ tumor stage, ↑ histological grade, ↓ overall survival | Yes | [74,75] |
Adenocarcinoma | Tumor-suppressing | ↑ survival | Yes | [78] |
Gastric adenocarcinoma | Tumor-suppressing | Localized disease, intestinal histological type, ↑ overall survival | Yes | [88] |
Colorectal adenocarcinoma | Tumor-suppressing | ↑ survival | Yes | [25,96] |
Hepatocellular carcinoma | Tumor-suppressing | No | [108] | |
Pancreatic ductal adenocarcinoma | Tumor-promoting | ↑ histological grade, ↓ disease-free survival | Yes | [119] |
- Citation: Xanthoulis A, Tiniakos DG. E2F transcription factors and digestive system malignancies: How much do we know? World J Gastroenterol 2013; 19(21): 3189-3198
- URL: https://www.wjgnet.com/1007-9327/full/v19/i21/3189.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i21.3189